NN, Inc. Executive Management to Present at the Gabelli Funds 48th Annual Automotive Symposium
November 02, 2024 18:00 ET
|
NN, Inc.
CHARLOTTE, N.C., Nov. 02, 2024 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies,...
Merus gibt Finanzergebnisse für das dritte Quartal 2024 bekannt und informiert über den aktuellen Geschäftsverlauf
November 02, 2024 06:18 ET
|
Merus N.V.
Phase-III-Zulassungsstudien zur Bewertung von Petosemtamab in Kombination mit Pembrolizumab in der Erstlinie und Petosemtamab-Monotherapie gegen rezidivierenden/metastasierendes Plattenepithelkarzinom...
Merus annonce ses résultats financiers pour le troisième trimestre 2024 et fait le point sur ses activités
November 02, 2024 06:18 ET
|
Merus N.V.
L’inclusion est en cours pour les essais d’enregistrement de phase III, pour l’évaluation du pétosemtamab en association avec le pembrolizumab en traitement de 1re intention, et pour l’évaluation du...
Founder Group Limited 宣布签订一份价值 380 万美元的新太阳能 EPCC 光伏合同
November 02, 2024 00:44 ET
|
Founder Group Ltd
雪兰莪，马来西亚, Nov. 02, 2024 (GLOBE NEWSWIRE) -- Founder Group Limited（简称“FGL”或“公司”）是马来西亚领先的太阳能光伏系统工程、采购、建设和调试 (EPCC) 解决方案供应商，今日宣布其子公司 Founder Energy Sdn Bhd 已获得一份合同，为马来西亚一家高等教育机构开发太阳能发电系统。 该合同涵盖了现场太阳能光伏...
Founder Group Limited 宣佈獲得價值 380 萬美元的太陽能光伏工程、採購、建設及調試（EPCC）新合約
November 02, 2024 00:44 ET
|
Founder Group Ltd
雪蘭莪，馬來西亞, Nov. 02, 2024 (GLOBE NEWSWIRE) -- 馬來西亞領先的太陽能光伏系統工程、採購、建設及調試（EPCC）解決方案提供商 Founder Group Limited（「FGL」或「公司」），今天宣佈其附屬公司 Founder Energy Sdn Bhd 已獲得為一所馬來西亞高等教育院校開發太陽能系統的合約。...
CORRECTION - Bogota Financial Corp. Reports Results for the Three and Nine Months Ended September 30, 2024 Corrected
November 01, 2024 21:00 ET
|
Bogota Savings Bank
TEANECK, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Bogota Financial Corp. (NASDAQ: BSBK) (the “Company”), the holding company of Bogota Savings Bank (the “Bank”), after market close today issued a...
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 19:04 ET
|
ZENTALIS PHARMACEUTICALS
SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small...
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 18:32 ET
|
LENSAR, Inc.
ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...
Beasley Broadcast Group to Report 2024 Third Quarter Financial Results, Host Conference Call and Webcast on November 5
November 01, 2024 17:58 ET
|
Beasley Broadcast Group, Inc.
NAPLES, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Beasley Broadcast Group, Inc. (Nasdaq: BBGI) (“Beasley” or the “Company”), a multi-platform media company, announced today that it will report its...
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
November 01, 2024 17:30 ET
|
ALX Oncology
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing...